Trial Profile
A prospective non-comparative study of biapenem in elderly Chinese patients with lower respiratory tract infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Biapenem (Primary)
- Indications Respiratory tract infections
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2015 New trial record
- 02 Oct 2015 Results published in the Journal of Chemotherapy